HER2-low status discordance between primary and recurrent/metastatic breast cancer in a large-scale cohort

被引：0
|
作者：
Lin, Mingxi
Luo, Ting
Zhang, Hui
Yang, Wentao
Zhang, Jian
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Sichuan Univ, West China Hosp, Breast Dis Ctr, Chengdu, Sichuan, Peoples R China
[3] Northwestern Univ, Dept Prevent Med, Div Biostat, Chicago, IL USA
[4] Fudan Univ, Dept Breast & Urol Med Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China
[5] Fudan Univ, Shanghai Med Coll, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1021
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Discordance of HER2-Low between Primary Tumors and Matched Distant Metastases in Breast Cancer
    Almstedt, Katrin
    Krauthauser, Lisa
    Kappenberg, Franziska
    Wagner, Daniel-Christoph
    Heimes, Anne-Sophie
    Battista, Marco J. J.
    Anic, Katharina
    Krajnak, Slavomir
    Lebrecht, Antje
    Schwab, Roxana
    Brenner, Walburgis
    Weikel, Wolfgang
    Rahnenfuehrer, Joerg
    Hengstler, Jan G. G.
    Roth, Wilfried
    Hasenburg, Annette
    Stewen, Kathrin
    Schmidt, Marcus
    CANCERS, 2023, 15 (05)
  • [2] HER2-low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis
    Lin, Mingxi
    Luo, Ting
    Jin, Yizi
    Zhong, Xiaorong
    Zheng, Dan
    Zeng, Cheng
    Guo, Qing
    Wu, Jiong
    Shao, Zhi-Ming
    Hu, Xichun
    Yang, Wentao
    Zhang, Jian
    CANCER, 2024, 130 (06) : 851 - 862
  • [3] Discordance of HER2-Low Status Between Breast Primary and Distant Metastases with Clinical-pathological Correlation
    Yang, Ellen
    D'Alfonso, Timothy
    Brogi, Edi
    Wen, Hannah
    LABORATORY INVESTIGATION, 2024, 104 (03) : S315 - S317
  • [4] Efficacy of HER2 inhibitors in metastatic breast cancer by discordance in HER2 amplification status between primary and metastatic breast cancer
    Van Raemdonck, E.
    Berteloot, P.
    Laenen, A.
    Han, S.
    Van Nieuwenhuysen, E.
    Salihi, R.
    Concin, N.
    Vergote, I.
    Floris, G.
    Wildiers, H.
    Punie, K.
    Neven, P.
    CANCER RESEARCH, 2019, 79 (04)
  • [5] Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort
    Grinda, Thomas
    Joyon, Natacha
    Lusque, Amelie
    Lefevre, Sarah
    Arnould, Laurent
    Penault-Llorca, Frederique
    Macgrogan, Gaetan
    Treilleux, Isabelle
    Vincent-Salomon, Anne
    Haudebourg, Juliette
    Maran-Gonzalez, Aurelie
    Charafe-Jauffret, Emmanuelle
    Courtinard, Coralie
    Franchet, Camille
    Verriele, Veronique
    Brain, Etienne
    Tas, Patrick
    Blanc-Fournier, Cecile
    Leroux, Agnes
    Loussouarn, Delphine
    Berghian, Anca
    Brabencova, Eva
    Ghnassia, Jean Pierre
    Scoazec, Jean-Yves
    Delaloge, Suzette
    Filleron, Thomas
    Lacroix-Triki, Magali
    NPJ BREAST CANCER, 2021, 7 (01)
  • [6] Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort
    Thomas Grinda
    Natacha Joyon
    Amélie Lusque
    Sarah Lefèvre
    Laurent Arnould
    Frédérique Penault-Llorca
    Gaëtan Macgrogan
    Isabelle Treilleux
    Anne Vincent-Salomon
    Juliette Haudebourg
    Aurélie Maran-Gonzalez
    Emmanuelle Charafe-Jauffret
    Coralie Courtinard
    Camille Franchet
    Véronique Verriele
    Etienne Brain
    Patrick Tas
    Cécile Blanc-Fournier
    Agnès Leroux
    Delphine Loussouarn
    Anca Berghian
    Eva Brabencova
    Jean Pierre Ghnassia
    Jean-Yves Scoazec
    Suzette Delaloge
    Thomas Filleron
    Magali Lacroix-Triki
    npj Breast Cancer, 7
  • [7] Evolution of HER2-low expression from primary to recurrent breast cancer
    Miglietta, Federica
    Griguolo, Gaia
    Bottosso, Michele
    Giarratano, Tommaso
    Lo Mele, Marcello
    Fassan, Matteo
    Cacciatore, Matilde
    Genovesi, Elisa
    De Bartolo, Debora
    Vernaci, Grazia
    Amato, Ottavia
    Conte, PierFranco
    Guarneri, Valentina
    Dieci, Maria Vittoria
    NPJ BREAST CANCER, 2021, 7 (01)
  • [8] Evolution of HER2-low expression from primary to recurrent breast cancer
    Federica Miglietta
    Gaia Griguolo
    Michele Bottosso
    Tommaso Giarratano
    Marcello Lo Mele
    Matteo Fassan
    Matilde Cacciatore
    Elisa Genovesi
    Debora De Bartolo
    Grazia Vernaci
    Ottavia Amato
    PierFranco Conte
    Valentina Guarneri
    Maria Vittoria Dieci
    npj Breast Cancer, 7
  • [9] Frequency and prognosis of HER2-low status in Mexican patients with metastatic breast cancer
    Martinez-Cannon, Bertha Alejandra
    Verduzco-Aguirre, Haydee Cristina
    CANCER RESEARCH, 2023, 83 (05)
  • [10] HER2-Low Expression in Metastatic Breast Cancer: Discordance in Patients with both Cytology and Surgical Pathology Specimens
    Glasgow, Akisha
    VanderLaan, Paul
    Collins, Laura
    Quintana, Liza
    LABORATORY INVESTIGATION, 2023, 103 (03) : S302 - S303
12345